Acebutolol
Bimatoprost may increase the hypotensive activities of Acebutolol.
Aceclofenac
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Aceclofenac.
Acemetacin
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Acemetacin.
Advertisement
Acetyl salicylate
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Acetylsalicylic acid.
Adapalene
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Adapalene.
Alfuzosin
Alfuzosin may increase the hypotensive activities of Bimatoprost.
Advertisement
Aliskiren
Bimatoprost may increase the hypotensive activities of Aliskiren.
Alminoprofen
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Alminoprofen.
Alprenolol
Alprenolol may increase the hypotensive activities of Bimatoprost.
Advertisement
Ambrisentan
Bimatoprost may increase the hypotensive activities of Ambrisentan.
Amifostine
Bimatoprost may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Bimatoprost may increase the hypotensive activities of Amifostine.
Amlodipine
Amlodipine may increase the hypotensive activities of Bimatoprost.
Amphetamine
Amphetamine may increase the hypotensive activities of Bimatoprost.
Antipyrine
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Antipyrine.
Apazone
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Azapropazone.
Apremilast
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Apremilast.
Aspirin
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Acetylsalicylic acid.
Atenolol
Atenolol may increase the hypotensive activities of Bimatoprost.
Avanafil
Avanafil may increase the antihypertensive activities of Bimatoprost.
Azelastine
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Azelastine.
Balsalazide
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Balsalazide.
Benazepril
Benazepril may increase the hypotensive activities of Bimatoprost.
Bendroflumethiazide
Bendroflumethiazide may increase the hypotensive activities of Bimatoprost.
Benzydamine
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Benzydamine.
Bepridil
Bimatoprost may increase the hypotensive activities of Bepridil.
Betaxolol
Betaxolol may increase the hypotensive activities of Bimatoprost.
Bethanidine
Bethanidine may increase the hypotensive activities of Bimatoprost.
Bisoprolol
Bisoprolol may increase the hypotensive activities of Bimatoprost.
Bosentan
Bosentan may increase the hypotensive activities of Bimatoprost.
Bosentan Anhydrous
Bosentan may increase the hypotensive activities of Bimatoprost.
Bretylium
Bimatoprost may increase the hypotensive activities of Bretylium.
Brimonidine
Brimonidine may increase the antihypertensive activities of Bimatoprost.
Bromfenac
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Bromfenac.
Bufexamac
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Bufexamac.
Bupranolol
Bimatoprost may increase the hypotensive activities of Bupranolol.
Cafedrine
Bimatoprost may increase the hypotensive activities of Cafedrine.
Candesartan
Bimatoprost may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Candesartan cilexetil may increase the hypotensive activities of Bimatoprost.
Captopril
Bimatoprost may increase the hypotensive activities of Captopril.
Carprofen
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Carprofen.
Carteolol
Carteolol may increase the hypotensive activities of Bimatoprost.
Carvedilol
Bimatoprost may increase the hypotensive activities of Carvedilol.
Celecoxib
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Celecoxib.
Celiprolol
Bimatoprost may increase the hypotensive activities of Celiprolol.
Chloroquine
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Chloroquine.
Chlorothiazide
Chlorothiazide may increase the hypotensive activities of Bimatoprost.
Chlorthalidone
Chlorthalidone may increase the hypotensive activities of Bimatoprost.
Choline Magnesium Trisalicyclate
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Choline magnesium trisalicylate.
Cicletanine
Bimatoprost may increase the hypotensive activities of Cicletanine.
Cilazapril
Bimatoprost may increase the hypotensive activities of Cilazapril.
Clonidine
Clonidine may increase the hypotensive activities of Bimatoprost.
Clonixin
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Clonixin.
Cryptenamine
Cryptenamine may increase the hypotensive activities of Bimatoprost.
Curcumin
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Curcumin.
Cyclopenthiazide
Bimatoprost may increase the hypotensive activities of Cyclopenthiazide.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Bimatoprost.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Bimatoprost.
Deserpidine
Bimatoprost may increase the hypotensive activities of Deserpidine.
Diazoxide
Diazoxide may increase the hypotensive activities of Bimatoprost.
Diclofenac
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Diclofenac.
Diflunisal
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Diflunisal.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Bimatoprost.
Diltiazem
Diltiazem may increase the hypotensive activities of Bimatoprost.
Dipyridamole
Dipyridamole may increase the antihypertensive activities of Bimatoprost.
Dipyrone
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Metamizole.
Dorzolamide
Dorzolamide may increase the hypotensive activities of Bimatoprost.
Doxazosin
Doxazosin may increase the hypotensive activities of Bimatoprost.
Droxicam
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Droxicam.
Enalapril
Enalapril may increase the hypotensive activities of Bimatoprost.
Enalaprilat
Bimatoprost may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Bimatoprost may increase the hypotensive activities of Enalaprilat.
Epoprostenol
Bimatoprost may increase the hypotensive activities of Epoprostenol.
Eprosartan
Eprosartan may increase the hypotensive activities of Bimatoprost.
Etanercept
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Etanercept.
Etodolac
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Etodolac.
Etofenamate
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Etofenamate.
Etoricoxib
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Etoricoxib.
Evening primrose oil
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Evening primrose oil.
Felbinac
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Felbinac.
Felodipine
Bimatoprost may increase the hypotensive activities of Felodipine.
Fenbufen
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Fenbufen.
Fenoldopam
Fenoldopam may increase the hypotensive activities of Bimatoprost.
Fenoprofen
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Fenoprofen.
Ferulic Acid
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Ferulic acid.
Floctafenine
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Floctafenine.
Flurbiprofen
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Flurbiprofen.
Fosinopril
Fosinopril may increase the hypotensive activities of Bimatoprost.
Fostamatinib
Fostamatinib may increase the antihypertensive activities of Bimatoprost.
Furazolidone
Furazolidone may increase the hypotensive activities of Bimatoprost.
Guanabenz
Guanabenz may increase the hypotensive activities of Bimatoprost.
Guanadrel
Guanadrel may increase the hypotensive activities of Bimatoprost.
Guanethidine
Bimatoprost may increase the hypotensive activities of Guanethidine.
Guanfacine
Guanfacine may increase the hypotensive activities of Bimatoprost.
Hydralazine
Hydralazine may increase the hypotensive activities of Bimatoprost.
Hydrochlorothiazide
Bimatoprost may increase the hypotensive activities of Hydrochlorothiazide.
Hydroflumethiazide
Hydroflumethiazide may increase the hypotensive activities of Bimatoprost.
Ibuprofen
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Ibuprofen.
Icatibant
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Icatibant.
Iloprost
Iloprost may increase the hypotensive activities of Bimatoprost.
Imidapril
Bimatoprost may increase the hypotensive activities of Imidapril.
Indapamide
Indapamide may increase the hypotensive activities of Bimatoprost.
Indobufen
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Indobufen.
Indomethacin
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Indomethacin.
Indoramin
Indoramin may increase the hypotensive activities of Bimatoprost.
Iproniazid
Iproniazid may increase the hypotensive activities of Bimatoprost.
Irbesartan
Bimatoprost may increase the hypotensive activities of Irbesartan.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Bimatoprost.
Isradipine
Isradipine may increase the hypotensive activities of Bimatoprost.
Kebuzone
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Kebuzone.
Ketanserin
Ketanserin may increase the hypotensive activities of Bimatoprost.
Ketoprofen
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Ketoprofen.
Ketorolac
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Ketorolac.
Labetalol
Labetalol may increase the hypotensive activities of Bimatoprost.
Lacidipine
Bimatoprost may increase the hypotensive activities of Lacidipine.
Latanoprost
The risk or severity of intraocular pressure can be increased when Latanoprost is combined with Bimatoprost.
Leflunomide
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Leflunomide.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Bimatoprost.
Limonene, (+)-
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with (4R)-limonene.
Lisinopril
Lisinopril may increase the hypotensive activities of Bimatoprost.
Lisinopril Anhydrous
Lisinopril may increase the hypotensive activities of Bimatoprost.
Lofexidine
Bimatoprost may increase the hypotensive activities of Lofexidine.
Lornoxicam
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Lornoxicam.
Losartan
Losartan may increase the hypotensive activities of Bimatoprost.
Loxoprofen
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Loxoprofen.
Macitentan
Bimatoprost may increase the hypotensive activities of Macitentan.
Magnesium Salicylate
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Magnesium salicylate.
Manidipine
Bimatoprost may increase the hypotensive activities of Manidipine.
Masoprocol
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Masoprocol.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Bimatoprost.
Meclofenamate
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Meclofenamic acid.
Meclofenamic Acid
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Meclofenamic acid.
Mefenamic Acid
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Mefenamic acid.
Meloxicam
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Meloxicam.
Mepirodipine
Bimatoprost may increase the antihypertensive activities of Barnidipine.
Mesalamine
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Mesalazine.
Methyldopa
Bimatoprost may increase the hypotensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Bimatoprost may increase the hypotensive activities of Methyldopa.
Methylene blue
Methylene blue may increase the hypotensive activities of Bimatoprost.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Bimatoprost.
Metipranolol
Bimatoprost may increase the hypotensive activities of Metipranolol.
Metolazone
Metolazone may increase the hypotensive activities of Bimatoprost.
Metoprolol
Metoprolol may increase the hypotensive activities of Bimatoprost.
Metyrosine
Bimatoprost may increase the hypotensive activities of Metyrosine.
Mibefradil
Bimatoprost may increase the hypotensive activities of Mibefradil.
Minaprine
Minaprine may increase the hypotensive activities of Bimatoprost.
Minoxidil
Minoxidil may increase the hypotensive activities of Bimatoprost.
Moclobemide
Moclobemide may increase the hypotensive activities of Bimatoprost.
Moexipril
Moexipril may increase the hypotensive activities of Bimatoprost.
Molsidomine
Molsidomine may increase the hypotensive activities of Bimatoprost.
Moxonidine
Moxonidine may increase the hypotensive activities of Bimatoprost.
MYCOPHENOLATE
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Mycophenolic acid.
Mycophenolate Mofetil
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Mycophenolate mofetil.
Mycophenolic Acid
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Mycophenolic acid.
Nabumetone
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Nabumetone.
Nadolol
Bimatoprost may increase the hypotensive activities of Nadolol.
Naftifine
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Naftifine.
Naproxen
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Naproxen.
Nebivolol
Bimatoprost may increase the hypotensive activities of Nebivolol.
Nepafenac
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Nepafenac.
Nialamide
Nialamide may increase the hypotensive activities of Bimatoprost.
Nicardipine
Nicardipine may increase the hypotensive activities of Bimatoprost.
Nicorandil
Bimatoprost may increase the hypotensive activities of Nicorandil.
Niflumic Acid
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Niflumic Acid.
Nilvadipine
Bimatoprost may increase the hypotensive activities of Nilvadipine.
Nimesulide
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Nimesulide.
Nimodipine
Nimodipine may increase the hypotensive activities of Bimatoprost.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Bimatoprost.
Nitrendipine
Bimatoprost may increase the hypotensive activities of Nitrendipine.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Bimatoprost.
Obinutuzumab
Bimatoprost may increase the hypotensive activities of Obinutuzumab.
Oenothera biennis seed extract
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Evening primrose oil.
Olmesartan
Olmesartan may increase the hypotensive activities of Bimatoprost.
Olopatadine
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Olopatadine.
Olsalazine
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Olsalazine.
Oxaprozin
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Oxaprozin.
Oxprenolol
Bimatoprost may increase the hypotensive activities of Oxprenolol.
Oxyphenbutazone
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Oxyphenbutazone.
Palmidrol
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Palmidrol.
Parecoxib
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Parecoxib.
Pargyline
Pargyline may increase the hypotensive activities of Bimatoprost.
Parthenolide
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Parthenolide.
Penbutolol
Bimatoprost may increase the hypotensive activities of Penbutolol.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Bimatoprost.
Perindopril
Perindopril may increase the hypotensive activities of Bimatoprost.
Phenelzine
Phenelzine may increase the hypotensive activities of Bimatoprost.
Phenoxybenzamine
Bimatoprost may increase the hypotensive activities of Phenoxybenzamine.
Phentolamine
Phentolamine may increase the hypotensive activities of Bimatoprost.
Phentolamine Mesylate
Phentolamine may increase the hypotensive activities of Bimatoprost.
Phenylbutazone
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Phenylbutazone.
Pimecrolimus
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Pimecrolimus.
Pinacidil
Pinacidil may increase the hypotensive activities of Bimatoprost.
Pindolol
Bimatoprost may increase the hypotensive activities of Pindolol.
Pirfenidone
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Pirfenidone.
Piroxicam
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Piroxicam.
Piroxicam-Beta-Cyclodextrin
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Piroxicam.
Polythiazide
Bimatoprost may increase the hypotensive activities of Polythiazide.
Prazosin
Prazosin may increase the hypotensive activities of Bimatoprost.
Procaine
Procaine may increase the hypotensive activities of Bimatoprost.
Procarbazine
Procarbazine may increase the hypotensive activities of Bimatoprost.
Propranolol
Propranolol may increase the hypotensive activities of Bimatoprost.
Quinapril
Quinapril may increase the hypotensive activities of Bimatoprost.
Quinine
Quinine may increase the hypotensive activities of Bimatoprost.
Ramipril
Ramipril may increase the hypotensive activities of Bimatoprost.
Rasagiline
Rasagiline may increase the hypotensive activities of Bimatoprost.
Rescinnamine
Bimatoprost may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Bimatoprost.
Resveratrol
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Resveratrol.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Bimatoprost.
Riociguat
Bimatoprost may increase the hypotensive activities of Riociguat.
Rituximab
Bimatoprost may increase the hypotensive activities of Rituximab.
Rofecoxib
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Rofecoxib.
Salicylamide
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Salicylamide.
Salicylic Acid
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Salicylic acid.
Salsalate
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Salsalate.
Selegiline
Selegiline may increase the hypotensive activities of Bimatoprost.
Selexipag
Bimatoprost may increase the hypotensive activities of Selexipag.
Serratiopeptidase
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Serrapeptase.
Sildenafil
Sildenafil may increase the antihypertensive activities of Bimatoprost.
Spirapril
Bimatoprost may increase the hypotensive activities of Spirapril.
Sulfasalazine
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Sulfasalazine.
Sulindac
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Sulindac.
Suprofen
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Suprofen.
Tadalafil
Tadalafil may increase the antihypertensive activities of Bimatoprost.
Talinolol
Bimatoprost may increase the hypotensive activities of Talinolol.
Telmisartan
Bimatoprost may increase the hypotensive activities of Telmisartan.
Tenoxicam
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Tenoxicam.
Teriflunomide
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Teriflunomide.
Terlipressin
Bimatoprost may increase the hypotensive activities of Terlipressin.
Theodrenaline
Bimatoprost may increase the hypotensive activities of Theodrenaline.
Theophylline
Theophylline may increase the antihypertensive activities of Bimatoprost.
Theophylline anhydrous
Theophylline may increase the antihypertensive activities of Bimatoprost.
Tiaprofenic Acid
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Tiaprofenic acid.
Tibolone
Bimatoprost may increase the hypotensive activities of Tibolone.
Timolol
Timolol may increase the hypotensive activities of Bimatoprost.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Bimatoprost.
Tolazoline
Tolazoline may increase the hypotensive activities of Bimatoprost.
Tolfenamic Acid
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Tolfenamic Acid.
Tolmetin
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Tolmetin.
Toloxatone
Toloxatone may increase the hypotensive activities of Bimatoprost.
Torsemide
Torasemide may increase the hypotensive activities of Bimatoprost.
Trandolapril
Trandolapril may increase the hypotensive activities of Bimatoprost.
Tranilast
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Tranilast.
Tranylcypromine
Tranylcypromine may increase the hypotensive activities of Bimatoprost.
Travoprost
Travoprost may increase the hypotensive activities of Bimatoprost.
Treprostinil
Treprostinil may increase the hypotensive activities of Bimatoprost.
Tribenoside
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Tribenoside.
Trichlormethiazide
Bimatoprost may increase the hypotensive activities of Trichlormethiazide.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Bimatoprost.
UNOPROSTONE
Bimatoprost may increase the hypotensive activities of Unoprostone.
Urapidil
Urapidil may increase the hypotensive activities of Bimatoprost.
Valdecoxib
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Valdecoxib.
Valsartan
Valsartan may increase the hypotensive activities of Bimatoprost.
Vardenafil
Vardenafil may increase the antihypertensive activities of Bimatoprost.
Vincamine
Bimatoprost may increase the hypotensive activities of Vincamine.
Vinpocetine
Bimatoprost may increase the hypotensive activities of Vinpocetine.
Xylometazoline
Bimatoprost may increase the hypotensive activities of Xylometazoline.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Bimatoprost.
Zileuton
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Zileuton.
Zofenopril
Bimatoprost may increase the hypotensive activities of Zofenopril.
Zomepirac
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Zomepirac.
